Stefan Michiels
Institut Gustave Roussy(FR)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Prostate Cancer Treatment and Research, Lung Cancer Treatments and Mutations, Fibroblast Growth Factor Research, Bladder and Urothelial Cancer Treatments
Most-Cited Works
- → Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98(2013)1,636 cited
- → Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial(2014)1,257 cited
- → Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group(2020)1,151 cited
- → CD4+ follicular helper T cell infiltration predicts breast cancer survival(2013)1,039 cited
- → Prediction of cancer outcome with microarrays: a multiple random validation strategy(2005)991 cited
- → Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers(2019)859 cited
- → Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data(2014)832 cited
- → Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors(2017)785 cited
- → High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial(2017)760 cited
- → Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research(2017)706 cited